Back to Results
First PageMeta Content
Clinical medicine / Medicine / Breakthrough therapy / Cancer / B-cell chronic lymphocytic leukemia / Obinutuzumab / Ofatumumab / Ibrutinib / Rituximab / Leukemia / Idelalisib / Phosphoinositide 3-kinase inhibitor


Interim statement from the BCSH CLL Guidelines Panel George A Follows1, Adrian Bloor2, Claire Dearden3, Steve Devereux4, Christopher P Fox5, Peter Hillmen6, Ben Kennedy7, Helen McCarthy8, Nilima Parry-Jones9, Piers EM Pa
Add to Reading List

Document Date: 2015-07-22 04:38:28


Open Document

File Size: 553,43 KB

Share Result on Facebook